- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04715178
Beat Childhood Cancer Specimen Banking and Data Registry
September 26, 2023 updated by: Giselle Sholler
Specimen Banking With Clinical and Genomic Data Registry With the Establishment of Tumor Models for Pediatric Cancers
This is an observational data registry study of all pediatric cancer patients at Atrium Health (AH) and participating Beat Childhood Cancer Consortium sites involving specimen banking and data collection.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This observational registry and banking study is being performed on a large cohort of patients who have been identified to receive molecular testing to better understand the relationship between genomic and molecular information and clinical outcomes, enabling timely and informed treatment decisions by physicians for cancer patients.
We hypothesize that large gene panels, sequencing (DNA/RNA), and epigenetics of tumors can identify molecular aberrations in tumors that can be leveraged to offer more effective treatment.
Findings may suggest additional research will be required to better understand the molecular underpinnings of the relationship between molecular abnormalities and disease.
Banked specimens and the creation of tumor cell lines and xenograft models will enable this research to be performed.
Study Type
Observational
Enrollment (Estimated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Genevieve Bergendahl, MSN
- Phone Number: 7175310003
- Email: gbergendahl@pennstatehealth.psu.edu
Study Contact Backup
- Name: Abigail Moore
- Phone Number: 7175310003
- Email: amoore13@pennstatehealth.psu.edu
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72202
- Recruiting
- Arkansas Children's Hospital
-
Principal Investigator:
- Kevin Bielamowicz, MD
-
Contact:
- Susan Hall
- Phone Number: 501-364-2760
- Email: HallSF@archildrens.org
-
-
Florida
-
Tampa, Florida, United States, 33614
- Recruiting
- St. Joseph's Children's Hospital
-
Principal Investigator:
- Don Eslin, MD
-
Contact:
- Jennifer Manns, RN
- Phone Number: 813-357-0849
- Email: jennifer.manns@baycare.org
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Recruiting
- Children's Mercy Hospitals and Clinics
-
Contact:
- Nicole Harvey
- Phone Number: 816-302-6893
- Email: ndharvey@cmh.edu
-
Principal Investigator:
- Kevin Ginn, MD
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Recruiting
- Levine Children's Hospital
-
Contact:
- Jotnyce Green
- Phone Number: 980-442-2356
- Email: jontyce.green@atriumhealth.org
-
Principal Investigator:
- Thomas Russell, MD
-
Winston-Salem, North Carolina, United States, 27157
- Recruiting
- Wake Forest University Health Sciences
-
Contact:
- Graham Keyes
- Email: grkeyes@wakehealth.edu
-
Principal Investigator:
- Sarah Supples, MD
-
Contact:
- L
-
-
Oregon
-
Portland, Oregon, United States, 97227
- Recruiting
- Randall Children's Hospital
-
Contact:
- Aaron White
- Email: AJWHITE@lhs.org
-
Principal Investigator:
- Jason Glover, MD
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
- Recruiting
- Penn State Milton S. Hershey Medical Center and Children's Hospital
-
Contact:
- Suzanne Treadway
- Email: streadway@hmc.psu.edu
-
Principal Investigator:
- Valerie Brown, MD
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Recruiting
- Medical University of South Carolina
-
Principal Investigator:
- Jaqueline Kraveka, MD
-
Contact:
- Shanta Salzar, MD
- Phone Number: 843-792-2957
- Email: salzers@musc.edu
-
-
Texas
-
Austin, Texas, United States, 78723
- Recruiting
- Dell Children's Blood and Cancer Center
-
Principal Investigator:
- Virginia Harrod, MD
-
Contact:
- Rhea Robinson, RN
- Phone Number: 512-628-1902
- Email: TXAUS-DL-SFCHemonc.research@ascension.org
-
-
Virginia
-
Norfolk, Virginia, United States, 23507
- Recruiting
- Children's Hospital of The King's Daughters
-
Contact:
- Sabrina Wigginton
- Email: Sabrina.Wigginton@chkd.org
-
Principal Investigator:
- Eric Lowe, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Pediatric cancer patients at participating Beat Childhood Cancer Consortium sites
Description
Inclusion Criteria:
- No age restrictions
- Patients with suspected or confirmed pediatric solid tumors
- Subject or his/her legally authorized representative (where applicable) signs the study consent.
Exclusion Criteria:
- Patient or his/her legally authorized representative (where applicable) did not consent for specimen banking and data collection for this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with suspected or confirmed pediatric solid tumors
|
No intervention- registry only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Create a data registry of clinical and molecular/genomic data
Time Frame: 10 years
|
Create a data registry of clinical and molecular/genomic data from cancer patients who have undergone biopsy or surgical resection for clinical care to better understand the relationship between genomic and molecular information and clinical outcomes.
|
10 years
|
Determine number and types of genomic alterations within tumor types/subtypes
Time Frame: 10 years
|
Define genomic landscape of pediatric cancers through the determination of the number and types of genomic alterations within tumor types/subtypes, across tumor types, and tumor evolution over time.
|
10 years
|
Evaluate the rate of actionable genomic alternations
Time Frame: 10 years
|
Evaluate the rate of actionable genomic alternations resulting in associated targeted therapies relative to all actionable genomic alterations.
|
10 years
|
Evaluate the correlation of baseline genomic alterations with clinical outcome.
Time Frame: 10 years
|
Evaluate the correlation of baseline genomic alterations with clinical outcome.
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bank additional specimens available for future research projects
Time Frame: 10 years
|
Bank additional specimens available for future research projects
|
10 years
|
Create cell line and xenograft models of pediatric cancers for future research
Time Frame: 10 years
|
Create cell line and xenograft models of pediatric cancers for future research
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Giselle Sholler, MD, Beat Childhood Cancer at Atrium Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 2, 2021
Primary Completion (Estimated)
January 1, 2031
Study Completion (Estimated)
January 1, 2032
Study Registration Dates
First Submitted
January 15, 2021
First Submitted That Met QC Criteria
January 15, 2021
First Posted (Actual)
January 20, 2021
Study Record Updates
Last Update Posted (Actual)
September 28, 2023
Last Update Submitted That Met QC Criteria
September 26, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- LCI-BCC-BIO-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancer
-
Emory UniversityNational Cancer Institute (NCI)Recruiting
-
Ann & Robert H Lurie Children's Hospital of ChicagoSilicon Valley Community FoundationUnknownCancer | Pediatric CancerUnited States
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Alexandria UniversityCompletedPediatric Cancer | Invasive CancerEgypt
-
Nemours Children's ClinicM.D. Anderson Cancer Center; University of Virginia; Children's Hospital Los...RecruitingPediatric CancerUnited States
-
Indiana UniversityNational Cancer Institute (NCI)Not yet recruitingPediatric Cancer
-
Wake Forest University Health SciencesAtrium Health Levine Cancer InstituteRecruitingPediatric CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisSociété Française des Cancers de l'Enfant (SFCE)Recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingPediatric CancerUnited States
-
Akdeniz UniversityCompletedPediatric CancerTurkey
Clinical Trials on No intervention- registry only
-
Abbott Medical DevicesTerminatedMitral RegurgitationUnited States
-
Centre Hospitalier de CayenneUnknown
-
Henry Ford Health SystemCompletedAcute Coronary SyndromeUnited States
-
University of Cape TownCompletedAcute Coronary Syndrome | Unstable Angina | ST Elevated Myocardial Infarction | Non ST Elevation Myocardial InfarctionSouth Africa
-
Sheba Medical CenterWithdrawn
-
Peking Union Medical College HospitalRecruitingRectal NeoplasmsChina
-
University of North Carolina, Chapel HillUniversity of South Carolina; East Carolina UniversityCompletedNon-small Cell Lung CancerUnited States
-
Universitair Ziekenhuis BrusselRecruiting
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior